Clinical trial
Prevention of Diabetes Progression Trial (PDPT)
NCT00198146 · Indiana University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00198146 |
|---|---|
| Title | Prevention of Diabetes Progression Trial (PDPT) |
| Official title | PD Initiated/Prevention of Diabetes Progression Trial (PDPT) ZEN119 |
| Lead sponsor | Indiana University School of Medicine, Other |
| Collaborators | Pescovitz, Mark D., M.D. Roche Pharma AG Industry Facet Biotech |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Newly Diagnosed With Type 1 Diabetes |
| Intervention type | Drug |
| Interventions | Zenapax |
| Enrollment | 40 |
| Start date | Jul 1, 2000 |
| Primary completion | Feb 23, 2007 |
| Completion | Feb 23, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Aug 11, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: